Estados financieros detallados de Adial Pharmaceuticals, Inc. (ADIL): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $5.24, ADIL presenta beneficios negativos (P/E no significativo) y un ROE del -16.93%. La capitalización bursátil es de $5M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $565 | $565 | $563 | $565 | $564 | 0 | 0 | $564 | 0 | 0 |
| Beneficio Bruto | -$565 | -$565 | -$563 | -$565 | -$564 | 0 | 0 | -$564 | 0 | 0 |
| I+D | $146143 | $182107 | $368459 | $4.0M | $5.9M | $8.4M | $2.0M | $1.3M | $3.2M | $2.6M |
| Generales y Administrativos | $264664 | $813179 | $6.6M | $4.3M | $5.1M | $9.3M | $8.9M | $5.6M | $5.1M | $5.2M |
| Gastos Operativos | $410807 | $995286 | $7.0M | $8.2M | $10.9M | $19.3M | $10.9M | $6.9M | $8.3M | $7.8M |
| Beneficio Operativo | -$410807 | -$995286 | -$7.0M | -$8.2M | -$10.9M | -$19.3M | -$10.9M | -$6.9M | -$8.3M | -$7.8M |
| EBITDA | -$410002 | -$994354 | -$7.0M | -$8.6M | -$10.9M | -$17.7M | -$10.8M | -$7.0M | -$13.2M | -$8.0M |
| Gastos por Intereses | $9643 | $144537 | $1.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$420200 | -$1.1M | -$11.6M | -$8.6M | -$10.9M | -$19.5M | -$10.8M | -$7.0M | -$13.2M | -$8.0M |
| Impuestos | 0 | $367 | 0 | 0 | -$32495 | -$94077 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$420200 | -$1.1M | -$11.6M | -$8.6M | -$10.9M | -$19.4M | -$12.7M | -$7.0M | -$13.2M | -$8.0M |
| BPA | $-55.00 | $-130.00 | $-1527.50 | $-545.00 | $-544.75 | $-653.00 | $-299.50 | $-136.00 | $-17.75 | $-11.93 |
| BPA Diluido | $-55.00 | $-130.00 | $-1527.50 | $-545.00 | $-544.75 | $-653.00 | $-299.50 | $-136.00 | $-17.75 | $-11.93 |
| Acciones en Circulación (Diluidas) | $7645 | $8760 | $7615 | $15764 | $19941 | $29742 | $42521 | $56986 | $743550 | $668630 |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 |
| Beneficio Operativo | -$1.8M | -$1.9M | -$2.0M | -$52.0M |
| EBITDA | -$1.8M | -$2.0M | -$2.0M | -$52.0M |
| Beneficio Neto | -$1.8M | -$2.0M | -$2.0M | -$52.0M |
| BPA | $-2.00 | $-1.80 | $-1.48 | $-11.25 |
| BPA Diluido | $-2.00 | $-1.80 | $-1.48 | $-11.25 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $87993 | $18248 | $3.9M | $6.8M | $4.4M | $6.1M | $4.0M | $2.8M | $3.8M | $5.9M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $35117 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $41758 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $141413 | $27248 | $4.7M | $7.7M | $5.1M | $6.5M | $4.8M | $3.2M | $4.1M | $6.2M |
| Inmovilizado Material | 0 | 0 | 0 | 0 | 0 | $304358 | $244421 | $3909 | 0 | 0 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | $248971 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $7863 | $7298 | $6735 | $6170 | $5606 | $5041 | $4477 | $3913 | $3348 | $2784 |
| Activos Totales | $151526 | $34546 | $4.7M | $7.7M | $5.5M | $7.6M | $5.7M | $4.7M | $5.0M | $6.8M |
| Cuentas por Pagar | $20012 | $342082 | $99671 | $190204 | $648739 | $286192 | $276410 | $103325 | $250130 | $655207 |
| Deuda a Corto | $234255 | $689265 | 0 | 0 | 0 | $49585 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $255019 | $1.0M | $257974 | $539051 | $1.5M | $2.7M | $1.8M | $653076 | $975858 | $1.4M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $255019 | $1.0M | $257974 | $539051 | $1.5M | $4.1M | $2.5M | $653513 | $975858 | $1.5M |
| Reservas | -$9.9M | -$403992 | -$12.0M | -$20.6M | -$31.5M | -$50.9M | -$63.7M | -$68.8M | -$82.0M | -$90.0M |
| Patrimonio Neto | -$103493 | -$997553 | $4.4M | $7.1M | $4.0M | $3.5M | $3.3M | $4.1M | $4.1M | $5.3M |
| Deuda Total | $234255 | $689265 | 0 | 0 | 0 | $256960 | $207375 | 0 | 0 | 0 |
| Deuda Neta | $146262 | $671017 | -$3.9M | -$6.8M | -$4.4M | -$5.8M | -$3.8M | -$2.8M | -$3.8M | -$5.9M |
| Capital Circulante | -$113606 | -$1.0M | $4.4M | $7.1M | $3.6M | $3.7M | $3.0M | $2.5M | $3.1M | $4.8M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $4.6M | $5.9M | $4.6M | $28.7M |
| Activos Totales | $5.7M | $6.8M | $5.2M | $29.1M |
| Pasivos Totales | $1.2M | $1.5M | $1.5M | $28.9M |
| Patrimonio Neto | $4.5M | $5.3M | $3.7M | $156000 |
| Deuda Total | 0 | 0 | 0 | 0 |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$420200 | -$1.1M | -$11.6M | -$8.6M | -$10.9M | -$19.4M | -$12.7M | -$7.0M | -$13.2M | -$8.0M |
| Amortizaciones | $565 | $565 | $563 | $565 | $564 | $55106 | $60501 | $564 | $565 | $565 |
| Compensación en Acciones | $153563 | $205396 | $5.4M | $1.6M | $2.0M | $4.2M | $3.4M | $1.7M | $796831 | $676200 |
| Cambio en Capital Circulante | -$8319 | $336370 | -$849315 | $208169 | $1.2M | $1.5M | -$1.4M | -$794205 | $386140 | $465673 |
| Flujo de Caja Operativo | -$274384 | -$494862 | -$2.5M | -$6.3M | -$7.6M | -$11.9M | -$11.2M | -$6.8M | -$6.9M | -$6.5M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 | 0 | -$64605 | 0 | $6.8M | 0 | $3 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | $30589 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$1661 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$274384 | -$494862 | -$2.5M | -$6.3M | -$7.6M | -$12.0M | -$11.2M | 0 | -$6.9M | -$6.5M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$1.8M | -$1.3M | -$1.6M | -$6.4M |
| Inversiones (CapEx) | $3 | -$4 | 0 | 0 |
| Flujo de Caja Libre | -$1.8M | -$1.3M | -$1.6M | -$6.4M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $147334 | $168036 | $147900 | $137100 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | -171.2% | -920.8% | +26.1% | -26.4% | -78.8% | +34.5% | +45.0% | -88.5% | +39.6% |
| Crecimiento BPA (anual) | | -136.4% | -1075.0% | +64.3% | +0.0% | -19.9% | +54.1% | +54.6% | +86.9% | +32.8% |
| Cambio en Acciones (anual) | | +14.6% | -13.1% | +107.0% | +26.5% | +49.1% | +43.0% | +34.0% | +1204.8% | -10.1% |
| Crecimiento FCF (anual) | | -80.4% | -404.9% | -153.7% | -20.4% | -57.4% | +6.9% | +100.0% | | +6.2% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | 0.3% | 0.5% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-35.89 | $-56.49 | $-328.09 | $-402.09 | $-382.79 | $-403.94 | $-263.07 | $0.00 | $-9.31 | $-9.71 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $7645 | $8760 | $7615 | $15764 | $19941 | $29742 | $42521 | $56986 | $743550 | $668630 |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -1693.21% |
| Rentabilidad sobre capital invertido | -240.64% |
| Rentabilidad sobre activos | -198.70% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 5.63 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -20.02 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -46.02 | -19.47 | -2.09 | -2.76 | -1.95 | -2.58 | -0.46 | -0.34 | -1.42 | -0.46 |
| P/VC | -186.98 | -22.23 | 5.49 | 3.33 | 5.32 | 14.31 | 1.78 | 0.65 | 4.62 | 0.70 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |